Results 61 to 70 of about 42,420 (122)

Genomic Insights into Candidozyma auris Clade II: Comparative Phylogenomics and Structural Validation of Fluconazole Resistance Mechanisms. [PDF]

J Fungi (Basel)
Lee S, Baritugo KG, Kim HS, Lee H, Ryu SW, Kim SY, Lee CH, Kim YR, Shin JH, Kim J, Sung GH.   +10 more
europepmc   +1 more source

Impact of Metal-Functionalized Fullerenes on the Proliferation of Pathogenic Fungi. [PDF]

ACS Omega
Ibrahim AA, Khan T, LaJeunesse D, Obare SO, Dellinger AL.   +4 more
europepmc   +1 more source

Catechin Augments the Antifungal Efficacy of Fluconazole Against Candida parapsilosis. [PDF]

Int J Mol Sci
Tóth Hervay N, Konečná A, Eliaš D, Kocúreková P, Jacko J, Súlovská H, Šikurová L, Gbelská Y.   +7 more
europepmc   +1 more source

Therapeutic Tools for Vulvovaginal Candidiasis: Current and Emerging Antifungal Agents. [PDF]

J Fungi (Basel)
Quindós G, De-la-Pinta I, Marcos-Arias C, Jauregizar N, Sevillano E, Madariaga L, Eraso E.   +6 more
europepmc   +1 more source

First report of Candidozyma auris in Vietnam. [PDF]

BMC Microbiol
Truong PT, Nguyen AT, Nguyen ST.
europepmc   +1 more source

Global prevalence and trends of fluconazole resistance in non-albicans Candida species: a systematic review and meta-analysis. [PDF]

BMC Infect Dis
Li X, Sholeh M, Moghadam MA, Ostadrahimi M, Hosseini SS.   +4 more
europepmc   +1 more source

Emerging fluconazole-resistant <i>Candida parapsilosis</i> in Australia: a case cluster and insights into the genetic diversity of this species. [PDF]

Front Microbiol
Perera M, Fong W, Haywood R, Sullivan GJ, Wang Q, Halliday CL, Dowsett-Moeahu S, Biswas C, Firacative C, Liu MC, Weeks K, Hardiman R, Kok J, Basile K, Meyer W, Sintchenko V, Chen SC, Kizny Gordon A.   +17 more
europepmc   +1 more source

Effectiveness and Safety of Empirical Antifungal Strategies in Critically Ill, Non-Neutropenic Patients: A Multi-Center Observational Study. [PDF]

Infect Drug Resist
Albakri SA, Aljabri AK, Alharbi EA, Alammash BB, Alabdali SA, Alahmadi MF, Almutairi NT, Alharbi HS, Alzahrani F, Alnezary FS.   +9 more
europepmc   +1 more source

Bioactive flavonoids from Anacardium occidentale as promising natural inhibitors of Cryptococcus neoformans: a computational perspective on secondary metabolites against critical fungal pathogens. [PDF]

Arch Microbiol
da Silva MVF, Silva J, de Oliveira VM, da Rocha MN, de Morais SM, Marinho ES.   +5 more
europepmc   +1 more source

In silico analysis of <i>Anacardium occidentale</i> phytochemicals: pharmacokinetics, molecular docking, and dynamics of <i>Cryptococcus neoformans</i> enzymes. [PDF]

In Silico Pharmacol
da Silva MVF, Silva J, da Rocha MN, de Morais SM, Marinho ES.   +4 more
europepmc   +1 more source